BoltzGen

Upload your target, choose the format you want — mini-protein, nanobody, antibody or peptide — and get back candidates, each refolded from its sequence to check the fold holds and ranked on its predicted interface with your target. Handles sugars and modified residues on the target natively.

What it is for

You have a target and have not settled on what shape the binder should be. One model here aims mini-proteins, nanobodies, antibodies or peptides at the same site, so you can compare formats instead of guessing. The only design tool here that handles sugars and modified residues on the target natively.

Designs a binder against your target, then refolds each candidate from its own sequence so you can see whether it holds the shape it was designed as. The interface score is the generator's own read, not a second opinion, so rank on it and re-fold a shortlist before you trust it. Four formats share one target — a small de novo protein, a nanobody, an antibody, or a short peptide — so you can compare formats on the same epitope rather than guessing which to commit to. It is the only design tool here that handles sugars, post-translational modifications and non-standard residues on the target natively. BoltzGen, Stark et al., bioRxiv 2025.

When it fits:

  • You have not settled on the binder format and want to aim mini-proteins, nanobodies, antibodies and peptides at the same site.
  • Your target carries sugars, modified residues or other chemistry a protein-only model would silently drop.
  • You want each design refolded on its own, so you can see whether it folds back to the shape it was designed as.
  • You can wait 15 to 60 minutes per run.

Inputs

You will need:

  • Target structure (.pdb / .cif).
  • Chain ID of the target.
  • At least one hotspot residue.

Each run uses a preset that sets the scale and scope:

Your target, ~30 min start to first results
Real BoltzGen run against your uploaded target. Pick 1 to 50 final candidates with refolding RMSD and ipTM scores. 4 is enough to read through while you confirm your target and binder length, and raising it on a later run returns more candidates against the same estimate. Results emailed when complete; A100-40GB.

Parameters you set on the form:

Protocol
BoltzGen design protocol. protein-anything for general mini-protein binders, nanobody-anything for VHH scaffolds, antibody-anything for antibody scaffolds, peptide-anything for short cyclic or linear peptides.
Hotspot residues
Comma-separated target-chain residue indices the binder should contact. Click residues in the 3D viewer to toggle.
Binder length (min/max)
Residue-count window for the generated binder. Typical starting ranges: mini-protein 50 to 100, nanobody 110 to 130, antibody 110 to 200, peptide 10 to 30. 10 is the shortest binder this tool accepts.
Budget (designs)
How many of the ranked candidates come back to you (1 to 50). This only chooses how many you receive: BoltzGen is asked for the same 200 candidates at every setting, so every budget quotes the same estimate.

Typical runtime:

pilot
15 to 60 min

How to read the results

Ranked candidate binders with ipTM, pLDDT, refolding RMSD, and downloadable PDBs. Refolding RMSD is the design against its own refold: at or under 2 Å it clears the RMSD leg of the pass bar, which also needs pLDDT at or above 80. Under 1.5 Å the results tooltip calls it self-consistent. That says the binder folds as designed, not that it binds — re-fold a shortlist against your target to check that.

Where a tool reports them, the scores mean:

ipTM
Predicted confidence in the contact between two chains, on a 0 to 1 scale. Higher is better, but BoltzGen's number is not on the shared scale the other tools are read against, so there is no cross-tool band to compare it to — rank on it, then re-fold a shortlist to confirm. On a multi-chain target the number may cover the target's own chain–chain interface as well as the binder's, so read the per-tool note on the results table before comparing designs on it.
pLDDT
Per-residue confidence in the predicted fold. Higher means the model is more sure of that part of the structure.
i_pAE and pAE
Predicted alignment error, at the interface (i_pAE) or across the whole structure (pAE). Lower is better.

References

Stark et al., bioRxiv 2025

Open the BoltzGen form All guides